Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
-
Published:2018-06
Issue:6
Volume:29
Page:1402-1408
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Abou-Alfa G.K.ORCID, Qin S., Ryoo B.-Y., Lu S.-N., Yen C.-J., Feng Y.-H., Lim H.Y., Izzo F., Colombo M., Sarker D., Bolondi L., Vaccaro G., Harris W.P., Chen Z., Hubner R.A., Meyer T., Sun W., Harding J.J., Hollywood E.M., Ma J., Wan P.J., Ly M., Bomalaski J., Johnston A., Lin C.-C., Chao Y., Chen L.-T.
Funder
Polaris Pharmaceuticals
Subject
Oncology,Hematology
Cited by
150 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|